C-Reactive Protein, Cardiac (hs-CRP) is a high-sensitivity test that measures low levels of CRP to assess cardiovascular disease risk. This test detects inflammation in the body at levels below what standard CRP tests can measure, making it particularly valuable for cardiovascular risk assessment in apparently healthy individuals. Elevated hs-CRP levels indicate increased inflammation, which is associated with atherosclerosis and cardiovascular events. The test helps stratify cardiovascular risk into three categories: low risk (<1.0 mg/L), average risk (1.0-3.0 mg/L), and high risk (>3.0 mg/L). This information can guide decisions about preventive treatments such as statin therapy in patients with intermediate cardiovascular risk. hs-CRP is particularly useful when combined with other risk factors to provide a more complete cardiovascular risk profile.